EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   6.3.1.13 | Breast Neoplasms |
16452219 |
Inhibition of glutamate cysteine ligase activity sensitizes human breast cancer cells to the toxicity of 2-deoxy-D-glucose. |
causal interaction
ongoing research
therapeutic application
unassigned |
3
4
1
0 |
| 6.3.1.13 | Colonic Neoplasms |
31018491 |
Anthocyanin Encapsulated by Ferulic Acid-Grafted-Maltodextrin (FA-g-MD) Microcapsules Potentially Improved its Free Radical Scavenging Capabilities Against H2O2-Induced Oxidative Stress. |
ongoing research
unassigned |
3
0 |
| 6.3.1.13 | Fibrosarcoma |
25393425 |
S-allyl cysteine activates the Nrf2-dependent antioxidant response and protects neurons against ischemic injury in vitro and in vivo. |
unassigned |
0 |
| 6.3.1.13 | Tuberculosis |
12033919 |
ATP-dependent L-cysteine:1D-myo-inosityl 2-amino-2-deoxy-alpha-D-glucopyranoside ligase, mycothiol biosynthesis enzyme MshC, is related to class I cysteinyl-tRNA synthetases. |
unassigned |
0 |
| 6.3.1.13 | Tuberculosis |
19525487 |
Dequalinium, a new inhibitor of Mycobacterium tuberculosis mycothiol ligase identified by high-throughput screening. |
therapeutic application
unassigned |
3
0 |
| 6.3.1.13 | Tuberculosis |
21392992 |
Susceptibility and mode of binding of the Mycobacterium tuberculosis cysteinyl transferase mycothiol ligase to tRNA synthetase inhibitors. |
therapeutic application
unassigned |
2
0 |
